✦ LIBER ✦

Integrated Safety Data From 4 Randomized, Double-Blind, Controlled Trials of Autologous Cellular Immunotherapy With Sipuleucel-T in Patients With Prostate Cancer

✍ Scribed by Hall, Simon J.; Klotz, Laurence; Pantuck, Allan J.; George, Daniel J.; Whitmore, James B.; Frohlich, Mark W.; Sims, Robert B.

Book ID: 118483444
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 85 KB
Volume: 186
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.04.070

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integrated data from 2 randomized, doubl

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

✍ Celestia S. Higano; Paul F. Schellhammer; Eric J. Small; Patrick A. Burch; John 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

## Abstract ## BACKGROUND: Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The safety and efficacy of sipuleucel‐T was evaluated in 2 identically designed, randomized, double‐blind, placebo‐controlled trials

Safety of formoterol in patients with as

Safety of formoterol in patients with asthma: Combined analysis of data from double-blind, randomized controlled trials

✍ Nelson, Harold; Bonuccelli, Catherine; Radner, Finn; Ottosson, Anders; Carroll, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 294 KB

1104 POSTER Patient-level integrated ana

1104 POSTER Patient-level integrated analysis of data from 6 randomized, double-blind, placebo-controlled trials of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA)

✍ H. Ludwig; J. Crawford; A. Österborg; A. Fleishman; T. Lillie; T. Süto; J. Glasp 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Efficacy and Safety of Short-Term Genist

Efficacy and Safety of Short-Term Genistein Intervention in Patients with Localized Prostate Cancer Prior to Radical Prostatectomy: A Randomized, Placebo-Controlled, Double-Blind Phase 2 Clinical Trial

✍ Lazarevic, Bato; Boezelijn, Gro; Diep, Lien My; Kvernrod, Kristin; Ogren, Olov; 📂 Article 📅 2011 🏛 Lawrence Erlbaum Associates, Inc. 🌐 English ⚖ 558 KB

1120 POSTER Evaluation of the associatio

1120 POSTER Evaluation of the association between hemoglobin (Hb) events and safety outcomes in cancer patients (pts) with chemotherapy-induced anemia (CIA): an integrated analysis of patient-level data from 6 randomized, placebo-controlled trials (RCTs) of darbepoetin alfa (DA)

✍ J. Glaspy; A. Österborg; H. Ludwig; A. Fleishman; T. Lillie; T. Süto; J. Crawfor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Final safety and efficacy analysis of th

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB